NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)
3 clinical trials · Sponsor
◉ Watch NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men (NCT02443090) | NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) | 2015-05-01 |
| Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis (NCT02228850) | NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) | 2014-11-01 |
| Safety and Pharmacokinetics of Terbinafine Hydrogen Chloride (HCl) Nail Lacquer in Patients With Onychomycosis (NCT00691184) | NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) | 2005-02-01 |
Track NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) automatically
Every clearance here is in the API, with alerts when new ones post.